Numonafide

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameNumonafide
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA intercalatorsTopoisomerase (DNA) II alpha inhibitors
TargetsTopoisomerase (DNA) II alphaDNA
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNorthwestern University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPanther Biotechnology IncNorthwestern University
Active IndicationsN/A
Inactive IndicationsSolid tumoursHematologic NeoplasmsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A